World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
40232
World Ranking
6554
National Ranking
251

Overview

Dirk De Ruysscher is affiliated with Maastricht University in the Netherlands and has an extensive research portfolio primarily in medicine, with a particular focus on pulmonary and respiratory medicine. Their work spans over 323 publications, covering significant areas such as oncology, radiology, nuclear medicine, and epidemiology.

Their research topics are centered on lung cancer, specifically in diagnosis, treatment, and mutations. Additionally, their work explores advanced radiotherapy techniques, radiomics and machine learning in medical imaging, cancer immunotherapy, biomarkers, and medical imaging techniques and applications.

  • Lung Cancer Diagnosis and Treatment
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer Immunotherapy and Biomarkers
  • Medical Imaging Techniques and Applications

They have published extensively in key journals in their field, including the following frequent publication venues:

  • Radiotherapy and Oncology
  • Annals of Oncology
  • Lung Cancer
  • Journal of Thoracic Oncology
  • International Journal of Radiation Oncology*Biology*Physics

Among their frequently collaborating co-authors are Lizza Hendriks, Maarten Lambrecht, Corinne Faivre-Finn, Stéphanie Peeters, and Petra Seibold, reflecting sustained partnerships in their research network.

Some recent notable papers authored or co-authored by Dirk De Ruysscher include:

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, 2021, Annals of Oncology
  • Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus, 2020, Annals of Oncology
  • ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma, 2020, European Respiratory Journal
  • Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology, 2020, OncoImmunology
  • Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14), 2020, Journal of Thoracic Oncology

Best Publications

  • Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    J. Vansteenkiste;D. De Ruysscher;W.E.E. Eberhardt;E. Lim

  • Small Cell Lung Cancer

    Jan P van Meerbeeck;Dean A Fennell;Dirk K M De Ruysscher

  • ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy)

    Alessandro Brunelli;Anne Charloux;Chris Thomas Bolliger;Gaetano Rocco

  • Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Reck;S Popat;N Reinmuth;Dirk De Ruysscher

  • Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    M Früh;Dirk De Ruysscher;S Popat;L Crinò

  • The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

    Kobe Reynders;Tim Illidge;Shankar Siva;Shankar Siva;Joe Y. Chang

  • 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

    J. Vansteenkiste;L. Crinò;C. Dooms;J. Y. Douillard

  • Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach.

    Johannes A. Langendijk;Philippe Lambin;Dirk De Ruysscher;Joachim Widder

  • 2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer

    W.E.E. Eberhardt;D. De Ruysscher;W. Weder;C. Le Péchoux

  • Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death

    Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert

  • Predicting outcomes in radiation oncology--multifactorial decision support systems

    Philippe Lambin;Ruud G. P. M. van Stiphout;Maud H. W. Starmans;Emmanuel Rios-Velazquez

  • Time Between the First Day of Chemotherapy and the Last Day of Chest Radiation Is the Most Important Predictor of Survival in Limited-Disease Small-Cell Lung Cancer

    Dirk De Ruysscher;Madelon Pijls-Johannesma;Søren M. Bentzen;André Minken

  • Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: A meta-analysis

    Janneke P.C. Grutters;Alfons G.H. Kessels;Madelon Pijls-Johannesma;Dirk De Ruysscher

  • Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non–Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

    Wilfried Ernst Erich Eberhardt;Christoph Pöttgen;Thomas Christoph Gauler;Godehard Friedel

  • Quantitative radiomics studies for tissue characterization: a review of technology and methodological procedures.

    Ruben T H M Larue;Gilles Defraene;Dirk De Ruysscher;Philippe Lambin

  • Radical Treatment of Non–Small-Cell Lung Cancer Patients with Synchronous Oligometastases: Long-Term Results of a Prospective Phase II Trial (Nct01282450)

    Dirk De Ruysscher;Rinus Wanders;Angela van Baardwijk;Anne-Marie C. Dingemans

  • Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

    Keith M. Kerr;Lukas Bubendorf;Martin J. Edelman;Antonio Marchetti

  • Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

    A.-M.C. Dingemans;M. Früh;A. Ardizzoni;B. Besse

  • European Organisation for Research and Treatment of Cancer Recommendations for Planning and Delivery of High-Dose, High-Precision Radiotherapy for Lung Cancer

    Dirk De Ruysscher;Corinne Faivre-Finn;Ursula Nestle;Coen W. Hurkmans

  • PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes.

    Angela van Baardwijk;Geert Bosmans;Liesbeth Boersma;Jeroen Buijsen

Frequent Co-Authors

Philippe Lambin
Philippe Lambin Maastricht University
Anne-Marie C. Dingemans
Anne-Marie C. Dingemans Erasmus University Rotterdam
Hugo J.W.L. Aerts
Hugo J.W.L. Aerts Brigham and Women's Hospital
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore
Cécile Le Péchoux
Cécile Le Péchoux Institut Gustave Roussy
Solange Peters
Solange Peters University Hospital of Lausanne
Catharine M L West
Catharine M L West University of Manchester
Manuela A. Joore
Manuela A. Joore Maastricht University Medical Centre
Alison M. Dunning
Alison M. Dunning University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For aspiring medical professionals or those looking to expand their expertise, numerous online degree options offer flexibility and career advancement. Some students interested in healthcare may choose to diversify their background before or during medical school. For example, earning a degree through the best online food science degree programs can open doors in nutrition, food safety, and public health nutrition, all of which complement medical training.

If healthcare management is your goal, consider enrolling in online mha programs cahme accredited to prepare for leadership in hospital or clinical settings. For registered nurses seeking further credentialing, there are rn to bsn online programs without clinicals that allow working professionals to advance their education while balancing current employment.

Finally, nurses looking for the fastest path to a doctoral degree can explore the fastest dnp program options online to reach the highest levels of practice and research. Each of these pathways can support a successful and flexible journey in the medical field, whether you’re preparing for medical school, advancing your current role, or exploring alternative healthcare careers.

Best Scientists Citing Dirk De Ruysscher

Trending Scientists

Recently Published Articles